Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project.
Mohammad A J AbdullaPrem ChandraSusanna El AkikiMahmood B AldaptSundus SardarAmmar ChapraAbdulqadir J NashwanClaudio SorioLuisa TomaselloChristian BoniMohamad A YassinPublished in: Cancer control : journal of the Moffitt Cancer Center (2022)
In the patient-cohort studied, there was no statistically significant difference in molecular response between patients with CML based on body weight or transcript type although patients in the obesity group achieved higher and faster MMR with no statistical significance.
Keyphrases
- body weight
- chronic myeloid leukemia
- end stage renal disease
- ejection fraction
- newly diagnosed
- insulin resistance
- chronic kidney disease
- prognostic factors
- weight loss
- tyrosine kinase
- peritoneal dialysis
- acute lymphoblastic leukemia
- case report
- body mass index
- physical activity
- weight gain
- patient reported outcomes
- patient reported
- single molecule
- solid state